United Therapeutics Corp.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $288.7M | $275.2M | $13.5M | $-21.1M |
| Mar 2023 | $374.8M | $333.5M | $41.3M | $-12.4M |
| Mar 2024 | $376.5M | $338.3M | $38.2M | $25.6M |
| Mar 2025 | $461.2M | $386.3M | $74.9M | $31.8M |
| Mar 2026 | $463.3M | $362.5M | $100.8M | $33.9M |